Clinical Trial: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
Study Status: Completed
Recruit Status: RECRUITING
Condition: Systemic Lupus Erythematosus
Study Type: INTERVENTIONAL
Official Title: A Phase Ib, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 Followi
Brief Summary:
The main purpose of this study is to evaluate the safety and tolerability of CUG252 following multiple ascending doses in participants with Systemic Lupus Erythematosus (SLE).
Read more